[Letter: 7 peripheral neuropathies after treatment by perhexiline maleate].
D002556:Cerebrospinal Fluid Proteins / Q000032:analysis; D003711:Demyelinating Diseases / Q000139:chemically induced; D006801:Humans; D010480:Perhexiline / Q000009:adverse effects* / Q000627:therapeutic use; D010880:Piperidines / Q000009:adverse effects*; D011128:Polyradiculopathy / Q000139:chemically induced*
D002556:Cerebrospinal Fluid Proteins; D010880:Piperidines; D010480:Perhexiline
Sept neuropathies périphériques après traitement par maléate de perhexéline